Combating chronic bacterial infections by manipulating cyclic nucleotide-regulated biofilm formation

Future Medicinal Chemistry

Volumn 8, Issue 9, 2016, Pages 949-961

  An, Shi Qi ^a   Ryan, Robert P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

antibiotic resistance; bacterial infection; biofilm formation; cyclic nucleotide signaling; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; CYCLIC AMP; CYCLIC DIGUANOSINE MONOPHOSPHATE; CYCLIC GMP; CYCLIC NUCLEOTIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL INFECTION; BIOFILM; CLINICAL PRACTICE; DRUG SCREENING; ENVIRONMENTAL FACTOR; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SECOND MESSENGER; BACTERIAL INFECTIONS; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; HUMANS; MICROBIAL SENSITIVITY TESTS; NUCLEOTIDES, CYCLIC; PSEUDOMONAS AERUGINOSA;

EID: 84975705929     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc-2015-0002     Document Type: Article

References (67)

1. Bjarnsholt T, Ciofu O, Molin S, Givskov M, HØiby N. Applying insights from biofilm biology to drug development-can a new approach be developed? Nat. Rev. Drug Discov. 12(10), 791-808 (2013).
2. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS. Suppl. (136), 1-51 (2013).
3. Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 20(5), 647-657 (2012).
4. Yousif A, Jamal MA, Raad I. Biofilm-based central line-associated bloodstream infections In: Biofilm-Based Healthcare-Associated Infections: Volume I. Donelli G (Ed.). Springer, Switzerland, 157-179 (2015).
5. Hobley L, Harkins C, MacPhee CE, Stanley-Wall NR. Giving structure to the biofilm matrix: an overview of individual strategies and emerging common themes. FEMS Microbiol. Rev. 39(5), 649-669 (2015).
6. Bjarnsholt T, Alhede M, Alhede M et al. The in vivo biofilm. Trends Microbiol. 21(9), 466-474 (2013).
7. van Delden C. Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int. J. Antimicrob. Agents 30, 71-75 (2007).
8. A report from the NNIS System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32(8), 470-485 (2004).
9. Hengge R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 7(4), 263-273 (2009).
10. Ausmees N, Mayer R, Weinhouse H et al. Genetic data indicate that proteins containing the GGDEF domain possess diguanylate cyclase activity. FEMS Microbiol. Lett. 204, 163-167 (2001).
11. Chan C, Paul R, Samoray D et al. Structural basis of activity and allosteric control of diguanylate cyclase. Proc. Natl Acad. Sci. USA 101(49), 17084-17089 (2004).
12. Schmidt AJ, Ryjenkov DA, Gomelsky M. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J. Bacteriol. 187(14), 4774-4781 (2005).
13. Ryan RP, Fouhy Y, Lucey JF et al. Cell-cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover. Proc. Natl Acad. Sci. USA 103(17), 6712-6717 (2006).
14. Cohen D, Mechold U, Nevenzal H et al. Oligoribonuclease is a central feature of cyclic diguanylate signaling in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 112(36), 11359-11364 (2015).
15. Orr MW, Donaldson GP, Severin GB et al. Oligoribonuclease is the primary degradative enzyme for pGpG in Pseudomonas aeruginosa that is required for cyclic-di-GMP turnover. Proc. Natl Acad. Sci. USA 112(36), E5048-E5057 (2015).
16. Ha D-G, Richman ME, O'Toole GA. Deletion mutant library for investigation of functional outputs of cyclic diguanylate metabolism in Pseudomonas aeruginosa PA14. Appl. Environ. Microbiol. 80(11), 3384-3393 (2014).
17. Trampari E, Stevenson CEM, Little RH, Wilhelm T, Lawson DM, Malone JG. Bacterial rotary export ATPases are allosterically regulated by the nucleotide second messenger cyclic-di-GMP. J. Biol. Chem. 290(40), 24470-24483 (2015).
18. Tschowri N, Schumacher MA, Schlimpert S et al. Tetrameric c-di-GMP mediates effective transcription factor dimerization to control Streptomyces development. Cell 158(5), 1136-1147 (2014).
19. Chambers JR, Liao J, Schurr MJ, Sauer K. BrlR from Pseudomonas aeruginosa is a c-di-GMP-responsive transcription factor. Mol. Microbiol. 92(3), 471-487 (2014).
20. An S, Caly DL, McCarthy Y et al. Novel cyclic di-GMP effectors of the YajQ protein family control bacterial virulence. PLoS Pathog. 10(10), e1004429 (2014).
21. McDonough KA, Rodriguez A. The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat. Rev. Microbiol. 10(1), 27-38 (2011).
22. Corrigan RM, Gründling A. Cyclic di-AMP: another second messenger enters the fray. Nat. Rev. Microbiol. 11(8), 513-524 (2013).
23. Marden JN, Dong Q, Roychowdhury S, Berleman JE, Bauer CE. Cyclic GMP controls Rhodospirillum centenum cyst development. Mol. Microbiol. 79(3), 600-615 (2011).
24. An S-Q, Chin K-H, Febrer M et al. A cyclic GMP-dependent signalling pathway regulates bacterial phytopathogenesis. EMBO J. 32(18), 2430-2438 (2013).
25. Davies BW, Bogard RW, Young TS, Mekalanos JJ. Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 149(2), 358-370 (2012).
26. Nelson JW, Sudarsan N, Phillips GE et al. Control of bacterial exoelectrogenesis by c-AMP-GMP. Proc. Natl Acad. Sci. USA 112(17), 5389-5394 (2015).
27. Kalia D, Merey G, Nakayama S et al. Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem. Soc. Rev. 42(1), 305-341 (2013).
28. Almblad H, Harrison JJ, Rybtke M et al. The cAMP-Vfr signaling pathway in Pseudomonas aeruginosa is inhibited by c-di-GMP. J. Bacteriol. 197(13), 2190-200 (2015).
29. Huynh TN, Luo S, Pensinger D, Sauer J-D, Tong L, Woodward JJ. An HD-domain phosphodiesterase mediates cooperative hydrolysis of c-di-AMP to affect bacterial growth and virulence. Proc. Natl Acad. Sci. USA 112(7), E747-E756 (2015).
30. Ha D-G, O'Toole GA. c-di-GMP and its effects on biofilm formation and dispersion: a Pseudomonas aeruginosa review. Microbiol. Spectr. 3(2), MB-003-2014 (2015).
31. Baraquet C, Harwood CS. Cyclic diguanosine monophosphate represses bacterial flagella synthesis by interacting with the Walker A motif of the enhancerbinding protein FleQ. Proc. Natl Acad. Sci. USA 110(46), 18478-18483 (2013).
32. Boehm A, Kaiser M, Li H et al. Second messenger-mediated adjustment of bacterial swimming velocity. Cell 141(1), 107-116 (2010).
33. Paul K, Nieto V, Carlquist WC, Blair DF, Harshey RM. The c-di-GMP binding protein YcgR controls flagellar motor direction and speed to affect chemotaxis by a "Backstop Brake" mechanism. Mol. Cell 38(1), 128-139 (2010).
34. Martínez-Granero F, Navazo A, Barahona E et al. Identification of flgZ as a flagellar gene encoding a PilZ domain protein that regulates swimming motility and biofilm formation in Pseudomonas. PLoS ONE 9(2), 1-10 (2014).
35. Kuchma SL, Delalez NJ, Filkins LM, Snavely EA, Armitage JP, O'Toole GA. c-di-GMP-mediated repression of swarming motility by Pseudomonas aeruginosa PA14 requires the MotAB stator. J. Bacteriol. 197(3), 420-430 (2014).
36. Moscoso JA, Jaeger T, Valentini M, Hui K, Jenal U, Filloux A. The diguanylate cyclase SadC is a central player in Gac/ Rsm-mediated biofilm formation in Pseudomonas aeruginosa. J. Bacteriol. 196(23), 4081-4088 (2014).
37. Kuchma SL, Brothers KM, Merritt JH, Liberati NT, Ausubel FM, O'Toole GA. BifA, a cyclic-di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 189(22), 8165-8178 (2007).
38. Guzzo CR, Dunger G, Salinas RK, Farah CS. Structure of the PilZ-FimX EAL-c-di-GMP complex responsible for the regulation of bacterial Type IV pilus biogenesis. J. Mol. Biol. 425(12), 2174-2197 (2013).
39. Huang B, Whitchurch CB, Mattick JS. FimX a multidomain protein connecting environmental signals to twitching motility in Pseudomonas aeruginosa. J. Bacteriol. 185(24), 7068-7076 (2003).
40. Huangyutitham V, Güvener Z, Harwood C. Subcellular clustering of the phosphorylated WspR response regulator protein stimulates its diguanylate cyclase activity. MBio 4(3), e00242-e00213 (2013).
41. Whitney JC, Colvin KM, Marmont LS, Robinson H, Parsek MR, Howell PL. Structure of the cytoplasmic region of PelD, a degenerate diguanylate cyclase receptor that regulates exopolysaccharide production in Pseudomonas aeruginosa. J. Biol. Chem. 287(28), 23582-23593 (2012).
42. Hay ID, Wang Y, Moradali MF, Rehman ZU, Rehm BH. Genetics and regulation of bacterial alginate production. Environ. Microbiol. 16(10), 2997-3011 (2014).
43. Wang Y, Hay ID, Rehman ZU, Rehm BH. Membraneanchored MucR mediates nitrate-dependent regulation of alginate production in Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 99(17), 7253-7265 (2015).
44. Hay ID, Remminghorst U, Rehm BH. MucR a novel membrane-associated regulator of alginate biosynthesis in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 75(4), 1110-1120 (2009).
45. Borlee BR, Goldman AD, Murakami K, Samudrala R, Wozniak DJ, Parsek MR. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol. Microbiol. 75(4), 827-842 (2010).
46. Rybtke M, Berthelsen J, Yang L, HØiby N, Givskov M, Tolker-Nielsen T. The LapG protein plays a role in Pseudomonas aeruginosa biofilm formation by controlling the presence of the CdrA adhesin on the cell surface. Microbiologyopen 4(6), 917-930 (2015).
47. Davies DG, Marques CNH. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191(5), 1393-1403 (2009).
48. Barraud N, Kelso MJ, Rice SA, Kjelleberg S. Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. Curr. Pharm. Des. 21, 31-42 (2015).
49. Sauer K, Cullen MC, Rickard AH, Zeef LAH, Gilbert P, Davies DG. Characterization of nutrientinduced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J. Bacteriol. 186(21), 7312-7326 (2004).
50. Li Y, Petrova OE, Su S et al. BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa. PLoS Pathog. 10(6), e1004168 (2014).
51. Li Y, Heine S, Entian M, Sauer K, Frankenberg-Dinkel N. NO-induced biofilm dispersion in Pseudomonas aeruginosa is mediated by an MHYT domain-coupled phosphodiesterase. J. Bacteriol. 195(16), 3531-3542 (2013).
52. Roy AB, Sauer K. Diguanylate cyclase NicD based signaling mechanism of nutrient-induced dispersion by Pseudomonas aeruginosa. Mol. Microbiol. 94(4), 771-793 (2014).
53. Petrova OE, Cherny KE, Sauer K. The diguanylate cyclase GcbA facilitates Pseudomonas aeruginosa biofilm dispersion by activating BdlA. J. Bacteriol. 197(1), 174-187 (2015).
54. McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S. Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat. Rev. Microbiol. 10(1), 39-50 (2011).
55. Lieberman OJ, Orr MW, Wang Y, Lee VT. High-throughput screening using the differential radial capillary action of ligand assay identifies ebselen as an inhibitor of diguanylate cyclases. ACS Chem. Biol. 9(1), 183-192 (2014).
56. Christensen LD, van Gennip M, Rybtke MT et al. Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic di-GMP level in the bacteria. Infect. Immun. 81(8), 2705-2713 (2013).
57. Sambanthamoorthy K, Gokhale AA, Lao W et al. Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner. Antimicrob. Agents Chemother. 55(9), 4369-4378 (2011).
58. Sambanthamoorthy K, Sloup RE, Parashar V et al. Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation. Antimicrob. Agents Chemother. 56(10), 5202-5211 (2012).
59. Sambanthamoorthy K, Luo C, Pattabiraman N et al. Identification of small molecules inhibiting diguanylate cyclases to control bacterial biofilm development. Biofouling 30(1), 17-28 (2014).
60. Barnes RJ, Bandi RR, Wong WS et al. Optimal dosing regimen of nitric oxide donor compounds for the reduction of Pseudomonas aeruginosa biofilm and isolates from wastewater membranes. Biofouling 29(2), 203-212 (2013).
61. Roelofs KG, Wang J, Sintim HO, Lee VT. Differential radial capillary action of ligand assay for high-throughput detection of protein-metabolite interactions. Proc. Natl Acad. Sci. USA 108(37), 15528-15533 (2011).
62. Amari DT, Marques CNH, Davies DG. The putative enoylcoenzyme A hydratase DspI is required for production of the Pseudomonas aeruginosa biofilm dispersion autoinducer cis-2-decenoic acid. J. Bacteriol. 195(20), 4600-4610 (2013).
63. Kellenberger CA, Wilson SC, Sales-Lee J, Hammond MC. RNA-based fluorescent biosensors for live cell imaging of second messengers cyclic di-GMP and cyclic AMP-GMP. J. Am. Chem. Soc. 135(13), 4906-4909 (2013).
64. Rybtke MT, Borlee BR, Murakami K et al. Fluorescencebased reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 78(15), 5060-5069 (2012).
65. Hall-Stoodley L, Stoodley P, Kathju S et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol. Med. Microbiol. 65(2), 127-145 (2012).
66. Coenye T, Nelis HJ. In vitro and in vivo model systems to study microbial biofilm formation. J. Microbiol. Methods 83(2), 89-105 (2010).
67. Chua SL, Liu Y, Yam JKH et al. Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles. Nat. Commun. 5, 4462 (2014).